Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MN-166
MN-166
FDA Grants Rare Pediatric Disease Designation to MediciNova’s MN-166 (ibudilast) for the Treatment of Krabbe Disease
Yahoo
Mon, 01/18/16 - 08:24 pm
FDA
MediciNova
MN-166
MediciNova Rises on FDA's Nod on MN-166 Study Initiation
Yahoo/Zacks.com
Thu, 08/28/14 - 07:25 pm
FDA
MediciNova
MN-166
Lou Gehrig's disease
amyotrophic lateral sclerosis
MediciNova Announces Positive Interim Results of Phase 2a Study of MN-166 (ibudilast) in Opioid Dependence
Yahoo
Tue, 08/19/14 - 08:13 am
MN-166
MediciNova
opioid addiction